In vitro neurotoxicity data in human risk assessment of polybrominated diphenyl ethers (PBDEs): Overview and perspectives

Toxicology in Vitro

Volumn 25, Issue 8, 2011, Pages 1509-1515

  Verner, Marc André ^a   Bouchard, Michèle ^b   Fritsche, Ellen ^c,d   Charbonneau, Michel ^e   Haddad, Sami ^b  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d RWTH AACHEN UNIVERSITY   (Germany)

^e INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Exposure assessment; In vitro in vivo extrapolation; Neurotoxicity; Polybrominated diphenyl ethers (PBDEs); Risk assessment

Indexed keywords

NEUROTOXIN; POLYBROMINATED DIPHENYL ETHER;

APOPTOSIS; BRAIN CELL; BRAIN DEVELOPMENT; BRAIN TISSUE; CANCER CELL; CELL MIGRATION; CHEMICAL INTERACTION; CHROMOSOME ABERRATION; CONCENTRATION RESPONSE; CYTOTOXICITY; DNA DAMAGE; DOSE RESPONSE; DOSIMETRY; ECOTOXICITY; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEUROTOXICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; PREDICTION; PRENATAL EXPOSURE; REVIEW; RISK ASSESSMENT; TISSUE LEVEL; TISSUE REACTION; TOXICOKINETICS; TOXIN ANALYSIS;

ANIMALS; BRAIN; CELL LINE; ENVIRONMENTAL POLLUTANTS; FLAME RETARDANTS; HALOGENATED DIPHENYL ETHERS; HUMANS; NEURAL STEM CELLS; RISK ASSESSMENT;

EID: 82655162206     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.06.007     Document Type: Review

References (53)

1. Antignac J.P., et al. Exposure assessment of French women and their newborn to brominated flame retardants: determination of tri- to deca-polybromodiphenylethers (PBDE) in maternal adipose tissue, serum, breast milk and cord serum. Environ. Pollut. 2009, 157:164-173.
2. Athanasiadou M., et al. Polybrominated diphenyl ethers (PBDEs) and bioaccumulative hydroxylated PBDE metabolites in young humans from Managua, Nicaragua. Environ. Health Perspect. 2008, 116:400-408.
3. Bal-Price A.K., et al. Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered. Neurotoxicol. Teratol. 2010, 32:36-41.
4. Bal-Price A.K., et al. In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints. Neurotoxicology 2010, 31:545-554.
5. Chevrier J., et al. Polybrominated diphenyl ether (PBDE) flame retardants and thyroid hormone during pregnancy. Environ. Health Perspect. 2010, 118:1444-1449.
6. Costa L.G., Giordano G. Developmental neurotoxicity of polybrominated diphenyl ether (PBDE) flame retardants. Neurotoxicology 2007, 28:1047-1067.
7. Covaci A., et al. Polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) in human liver and adipose tissue samples from Belgium. Chemosphere 2008, 73:170-175.
8. Davis, J.A., et al., 2010. Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1. Toxicol. Appl. Pharmacol. doi:. doi:10.1016/j.taap.2010.10.016.
9. de Wit C.A., et al. Brominated flame retardants in the Arctic environment - trends and new candidates. Sci. Total Environ. 2010, 408:2885-2918.
10. Dewailly E., et al. Concentration of organochlorines in human brain, liver, and adipose tissue autopsy samples from Greenland. Environ. Health Perspect. 1999, 107:823-828.
11. Emond C., et al. A physiologically based pharmacokinetic model for developmental exposure to BDE-47 in rats. Toxicol. Appl. Pharmacol. 2010, 242:290-298.
12. EPA, 1997. Exposure Factors Handbook, In: Protection, U.S.E., Agency, O.o.R.a.D. (Eds.), Washington, DC.
13. Ericson Jogsten I., et al. Analysis of POPs in human samples reveal a contribution of brominated dioxin of up to 15% of the total dioxin TEQ. Chemosphere 2010, 78:113-120.
14. Frederiksen M., et al. Polybrominated diphenyl ethers in paired samples of maternal and umbilical cord blood plasma and associations with house dust in a Danish cohort. Int. J. Hyg. Environ. Health 2010, 213:233-242.
15. Frederiksen M., et al. Human internal and external exposure to PBDEs - a review of levels and sources. Int. J. Hyg. Environ. Health 2009, 212:109-134.
16. Fritsche E., et al. Polychlorinated biphenyls disturb differentiation of normal human neural progenitor cells: clue for involvement of thyroid hormone receptors. Environ. Health Perspect. 2005, 113:871-876.
17. Gao P., et al. Influence of PCB153 on oxidative DNA damage and DNA repair-related gene expression induced by PBDE-47 in human neuroblastoma cells in vitro. Toxicol. Sci. 2009, 107:165-170.
18. Gaylor D., et al. Procedures for calculating benchmark doses for health risk assessment. Regul. Toxicol. Pharmacol. 1998, 28:150-164.
19. Gomara B., et al. Distribution of polybrominated diphenyl ethers in human umbilical cord serum, paternal serum, maternal serum, placentas, and breast milk from Madrid population, Spain. Environ. Sci. Technol. 2007, 41:6961-6968.
20. Gouin T., et al. Policy by analogy: precautionary principle, science and polybrominated diphenyl ethers. Int. J. Global Environ. Issues 2005, 5:54-67.
21. Haddad S., et al. Relative lipid content as the sole mechanistic determinant of the adipose tissue:blood partition coefficients of highly lipophilic organic chemicals. Chemosphere 2000, 40:839-843.
22. He W., et al. Effects of PBDE-47 on cytotoxicity and genotoxicity in human neuroblastoma cells in vitro. Mutat. Res. 2008, 649:62-70.
23. He P., et al. Mechanism of the neurotoxic effect of PBDE-47 and interaction of PBDE-47 and PCB153 in enhancing toxicity in SH-SY5Y cells. Neurotoxicology 2009, 30:10-15.
24. Herbstman J.B., et al. Prenatal Exposure to PBDEs and Neurodevelopment. Environ. Health Perspect 2010, 118:712-719.
25. Huwe J.K., et al. Tissue distribution of polybrominated diphenyl ethers in male rats and implications for biomonitoring. Environ. Sci. Technol. 2008, 42:7018-7024.
26. Kodavanti P.R., et al. Polybrominated diphenyl ether (PBDE) effects in rat neuronal cultures: 14C-PBDE accumulation, biological effects, and structure-activity relationships. Toxicol. Sci. 2005, 88:181-192.
27. Krishnan K., Andersen M.E. Physiologically Based Pharmacokinetic Modeling in Toxicology. Principles and Methods of Toxicology 2001, Raven Press, New York. third ed. A. Wallace Hayes (Ed.).
28. Kuo Y.M., et al. Bioaccumulation and biomagnification of polybrominated diphenyl ethers in a food web of Lake Michigan. Ecotoxicology 2010, 19:623-634.
29. Lanting C.I., et al. Polychlorinated biphenyls in adipose tissue, liver, and brain from nine stillborns of varying gestational ages. Pediatr. Res. 1998, 44:222-225.
30. Li F., et al. Hormone activity of hydroxylated polybrominated diphenyl ethers on human thyroid receptor-beta: in vitro and in silico investigations. Environ. Health Perspect. 2010, 118:602-606.
31. Li L., et al. Quantitative structure-property relationships for octanol-water partition coefficients of polybrominated diphenyl ethers. Chemosphere 2008, 72:1602-1606.
32. LoPachin R.M., Aschner M. Glial-neuronal interactions: relevance to neurotoxic mechanisms. Toxicol. Appl. Pharmacol. 1993, 118:141-158.
33. Lorber M. Exposure of Americans to polybrominated diphenyl ethers. J. Expo. Sci. Environ. Epidemiol. 2008, 18:2-19.
34. Madia F., et al. Differential in vitro neurotoxicity of the flame retardant PBDE-99 and of the PCB Aroclor 1254 in human astrocytoma cells. Toxicol. Lett. 2004, 154:11-21.
35. Marsh R., et al. Neuroimaging studies of normal brain development and their relevance for understanding childhood neuropsychiatric disorders. J. Am. Acad. Child Adolesc. Psychiatry 2008, 47:1233-1251.
36. Meironyte Guvenius D., et al. Polybrominated diphenyl ethers in Swedish human liver and adipose tissue. Arch. Environ. Contam. Toxicol. 2001, 40:564-570.
37. Moors M., et al. ERK-dependent and -independent pathways trigger human neural progenitor cell migration. Toxicol. Appl. Pharmacol. 2007, 221:57-67.
38. Moors M., et al. Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ. Health Perspect. 2009, 117:1131-1138.
39. Mundy W.R., et al. Accumulation of PBDE-47 in primary cultures of rat neocortical cells. Toxicol. Sci. 2004, 82:164-169.
40. Qiu X., et al. Hydroxylated metabolites of polybrominated diphenyl ethers in human blood samples from the United States. Environ. Health Perspect. 2009, 117:93-98.
41. Rahman F., et al. Polybrominated diphenyl ether (PBDE) flame retardants. Sci. Total Environ. 2001, 275:1-17.
42. Redding L.E., et al. Population physiologically based pharmacokinetic modeling for the human lactational transfer of PCB-153 with consideration of worldwide human biomonitoring results. Environ. Health Perspect. 2008, 116:1629-1635.
43. Roze E., et al. Prenatal exposure to organohalogens, including brominated flame retardants, influences motor, cognitive, and behavioral performance at school age. Environ. Health Perspect. 2009, 117:1953-1958.
44. Schreiber T., et al. Polybrominated diphenyl ethers induce developmental neurotoxicity in a human in vitro model: evidence for endocrine disruption. Environ. Health Perspect. 2010, 118:572-578.
45. Stapleton H.M., et al. Metabolism of polybrominated diphenyl ethers (PBDEs) by human hepatocytes in vitro. Environ. Health Perspect. 2009, 117:197-202.
46. Tagliaferri S., et al. Low concentrations of the brominated flame retardants BDE-47 and BDE-99 induce synergistic oxidative stress-mediated neurotoxicity in human neuroblastoma cells. Toxicol. In Vitro 2010, 24:116-122.
47. Toms L.M., et al. Higher accumulation of polybrominated diphenyl ethers in infants than in adults. Environ. Sci. Technol. 2008, 42:7510-7515.
48. Toms L.M., et al. Serum polybrominated diphenyl ether (PBDE) levels are higher in children (2-5 years of age) than in infants and adults. Environ. Health Perspect. 2009, 117:1461-1465.
49. Verner M.A., et al. A physiologically based pharmacokinetic model for the assessment of infant exposure to persistent organic pollutants in epidemiologic studies. Environ. Health Perspect. 2009, 117:481-487.
50. Verner M.A., et al. Alteration of infant attention and activity by polychlorinated biphenyls: unravelling critical windows of susceptibility using physiologically based pharmacokinetic modeling. Neurotoxicology 2010, 31:424-431.
51. White D.R., et al. The composition of body tissues (II) Fetus to young adult. Br. J. Radiol. 1991, 64:149-159.
52. Yla-Outinen L., et al. Human cell-based micro electrode array platform for studying neurotoxicity. Front Neuroengineering 2010, 3:111. 10.3389/fneng.2010.00111.
53. Yu K., et al. DE-71-induced apoptosis involving intracellular calcium and the Bax-mitochondria-caspase protease pathway in human neuroblastoma cells in vitro. Toxicol. Sci. 2008, 104:341-351.